Ascentage Pharma Group International Stock Analysis & AI Score
Ascentage Pharma Group International (AAPG) has an ST Score of 38.6 (C), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $40.00 price target (+162.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Ascentage Pharma Group International (AAPG) has an ST Score of 38.6 (C), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $40.00 price target (+162.6% upside).
- Strongest
- ForecastA
- Weakest
- Financial StrengthD-
All factor grades
- ForecastA
- GrowthB+
- ValuationC
- MomentumC-
- ProfitabilityD
- Financial StrengthD-
- Piotroski2/9
Contact
AAPG stock: frequently asked questions
What is AAPG's ST Score?
Ascentage Pharma Group International (AAPG) has an ST Score of 38.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AAPG a buy, hold, or sell?
Analysts rate AAPG a Buy, with a price target of $40.00 (+162.6% vs the current price). Our ST Score grades it C (38.6/100). The ST Score is a data-driven signal, not a recommendation.
What are AAPG's factor grades?
Valuation C, Profitability D, Financial Strength D-, Momentum C-, Growth B+, Forecast A.
What is AAPG's valuation grade?
Ascentage Pharma Group International (AAPG) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AAPG's growth grade?
Ascentage Pharma Group International (AAPG) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AAPG's profitability grade?
Ascentage Pharma Group International (AAPG) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AAPG's financial strength grade?
Ascentage Pharma Group International (AAPG) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AAPG?
The average analyst price target for Ascentage Pharma Group International (AAPG) is $40.00 from 1 analysts, which is +162.6% versus the recent price of $15.23.
What is AAPG's Piotroski score?
Ascentage Pharma Group International (AAPG) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.